Cost-Effectiveness of Different Strategies for the Treatment of Moderate-to-Severe Ulcerative Colitis

Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study

(2017) Julián Panés et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Ulcerative colitis

(2017) Ryan Ungaro et al.   LANCET

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

(2017) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis

(2017) Ewa Stawowczyk et al.   PHARMACOECONOMICS

Efficient Research Design

(2016) Edward C. F. Wilson et al.   MEDICAL DECISION MAKING

A Model-Based Economic Evaluation of Biologic and Non-Biologic Options for the Treatment of Adults with Moderately-to-Severely Active Ulcerative Colitis after the Failure of Conventional Therapy

(2016) Paul Tappenden et al.   PHARMACOECONOMICS

Cost-Utility Analysis of Infliximab with Standard Care versus Standard Care Alone for Induction and Maintenance Treatment of Patients with Ulcerative Colitis in Poland

(2016) Ewa Stawowczyk et al.   PHARMACOTHERAPY

Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland

(2016) Ewa Stawowczyk et al.   PLoS One

Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative Colitis

(2016) Adrian D. Vickers et al.   PLoS One

Low-dose Infliximab for Induction and Maintenance Treatment in Chinese Patients With Moderate to Severe Active Ulcerative Colitis

(2015) Xue-Liang Jiang et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Cancers Complicating Inflammatory Bowel Disease

(2015) Laurent Beaugerie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Indirect health costs in ulcerative colitis and Crohn’s disease: a systematic review and meta-analysis

(2015) Paweł Kawalec et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Network Meta-Analysis Using R: A Review of Currently Available Automated Packages

(2014) Binod Neupane et al.   PLoS One

Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis

(2013) William J. Sandborn et al.   GASTROENTEROLOGY

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2013) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Automating network meta-analysis

(2012) Gert van Valkenhoef et al.   Research Synthesis Methods

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

(2011) William J. Sandborn et al.   GASTROENTEROLOGY

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

(2011) W. Reinisch et al.   GUT

Systematic review: the costs of ulcerative colitis in Western countries

(2010) R. D. COHEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study

(2009) Corinne Gower-Rousseau et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY